{
  "trial_id": "NCT02923323",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "recruited",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "years old having diagnosed with T1DM for longer than 2 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Exclusions: head injuries, epileptic episodes, psychiatric medications, lack of Hebrew",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "abilities, disagreement to keep with all study requests, history of more than one episode of severe hypoglycemic event in the past, including loss of consciousness or more than one episode of diabetic ketoacidosis (DKA)",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Families living in areas with high access to medical care",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age:12-18 years old having diagnosed with T1DM for longer than 2 years",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "consent and children will assent, according to Ethics committee regulations, prior to beginning study sessions",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Procedures: Study design includes 3 sessions, which will be performed during a period of 2 -12 weeks, according to participants' convenience",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "The data acquired in each session will be analyzed both within groups and among groups in order to evaluate possible descriptive variables to performance differences among diabetic patients in addition to the expected differences between healthy and diabetic adolescents, and the expected difference between T1DM patients with variable glycemic control",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Session 1 - baseline visit: Signing parents' informed consent and participant assent. Medical history intake by the study physician including physical exam.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Physical examination will be performed including blood pressure, pulse, weight, height, BMI, pubertal stage, injection sites.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Specialized psychological neurocognitive team will perform neurocognitive studies to one of the parents and participants. Tests will be performed in a clinic setting in order to provide a baseline cognitive and lingual ability to continue in the next study sessions.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Capillary glucose assessment will be performed prior to testing to ensure glucose > 70 mg/dl.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has type 1 diabetes confirmed with molecular analysis 7 years ago. He presents to the clinic with shortness of breath and fatigue during activities.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT02923323",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}